Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Amino Acid Transporter ATB0,+ as a Delivery System for Drugs and Prodrugs
pp. 357-364(8)
Authors: Ganapathy, M. E.; Ganapathy, V.

Augmenting T Helper Cell Immunity in Cancer
pp. 365-371(7)
Authors: Knutson, K. L.; Disis, M. L.

Management of Liver Disease in Thalassemia: Main Drug Targets for a Correct Therapy
pp. 373-378(6)
Authors: Vecchio, G. C.D.; Nigro, A.; Giordano, P.; De Mattia, D.

Molecular Basis of Therapeutic Strategies for Breast Cancer
pp. 379-396(18)
Authors: Huang, Jing; Li, Xiaodong; Hilf, Russell; Bambara, Robert A.; Muyan, Mesut

The New Immunosuppression: Intervention at the Dendritic Cell-T-Cell Interface
pp. 397-411(15)
Authors: Paterson, A. M.; Yates, S. F.; Nolan, K. F.; Waldmann, H.

Failure of Immune Homeostasis - The Consequences of Under and Over Reactivity
pp. 413-423(11)
Authors: Crimeen-Irwin, B.; Scalzo, K.; Gloster, S.; Mottram, P. L.; Plebanski, M.

Insulin Regulation of PEPCK Gene Expression: A Model for Rapid and Reversible Modulation
pp. 423-437(15)
Authors: Quinn, P. G.; Yeagley, D.

Hormonal Effects on Drug Metabolism Through the CYP System: Perspectives on Their Potential Significance in the Era of Pharmacogenomics
pp. 439-448(10)
Authors: Sarlis, N. J.; Gourgiotis, L.

Signal Transducer and Activator of Transcription 5 (STAT5), a Crucial Regulator of Immune and Cancer Cells
pp. 449-463(15)
Authors: Wittig, Ilka; Groner, Bernd

Boosting Interleukin-10 Production: Therapeutic Effects and Mechanisms
pp. 465-475(11)
Authors: Zhou, Xiaoxia; Schmidtke, Peter; Zepp, Fred; Meyer, Claudius U.